[ad_1]
The Division of Funding and Public Asset Administration (DIPAM) had initially on December 14 invited preliminary bids for promoting the federal government’s 100 per cent stake within the well being sector CPSE.
The final date for submitting expression of curiosity (EoI) was January 31. This was later prolonged until February 28.
In a discover on its web site, DIPAM mentioned in view of additional requests acquired from the bidders to increase the deadline, the final date for submission of EoI has been prolonged until March 14.
The due date for intimation to Certified Bidders (QIBs) by DIPAM too has been prolonged by a fortnight until March 28.
HLL, a CPSE underneath Ministry of Well being and Household Welfare, is concerned in manufacturing and advertising of a spread of contraceptives, girls’s healthcare merchandise, hospital provides in addition to different pharmaceutical merchandise.
HLL can be engaged in offering healthcare and diagnostic companies, consultancy and contract companies for healthcare infrastructure tasks and consultancy companies for procurement of medical tools and units within the healthcare sector and caters to each home and worldwide markets.
As of March 31, 2021, HLL’s authorised capital was Rs 300 crore and its paid-up share capital was Rs 15.53 crore. With this deadline extension, the strategic sale of HLL Lifecare is now anticipated to spill over to the subsequent fiscal 12 months starting April 1.
The federal government has set a disinvestment goal of Rs 65,000 crore for 2022-23, down from Rs 78,000 crore estimated to be garnered this fiscal 12 months ending March 31.
[ad_2]
Source link
